|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,854 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,066,843 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
787,387 |
|
|
Total
Value |
$65,005,693 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
1
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-13.1%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
|
2024-05-21 |
9,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
852 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 35
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-03-04 |
4 |
AS |
$60.00 |
$300,000 |
I/I |
(5,000) |
13,545 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-03-26 |
4 |
AS |
$60.68 |
$728,147 |
I/I |
(12,000) |
13,545 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-02 |
4 |
S |
$65.62 |
$131,241 |
I/I |
(2,000) |
13,545 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-03 |
4 |
AS |
$67.21 |
$537,950 |
I/I |
(8,000) |
13,545 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-07 |
4 |
AS |
$65.87 |
$197,613 |
I/I |
(3,000) |
13,545 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Director |
|
2009-11-20 |
4 |
S |
$8.40 |
$16,865 |
D/D |
(2,000) |
13,621 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-06-01 |
4 |
AS |
$18.18 |
$183,293 |
D/D |
(10,000) |
13,695 |
0 |
- |
|
NGSX |
Neurogesx Inc |
See General Remarks |
|
2007-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,822 |
13,821 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
officerTitle |
|
2006-02-01 |
4 |
AB |
$11.62 |
$17,500 |
D/D |
1,500 |
14,000 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-12-08 |
4 |
B |
$17.20 |
$68,792 |
D/D |
4,000 |
14,917 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-05-02 |
4 |
AS |
$16.36 |
$24,647 |
D/D |
(1,500) |
15,142 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2023-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,505 |
15,493 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-03-01 |
4 |
AB |
$12.96 |
$19,490 |
D/D |
1,500 |
15,500 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-02 |
4 |
OE |
$12.99 |
$25,980 |
I/I |
2,000 |
15,545 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Director |
|
2009-11-19 |
4 |
S |
$8.15 |
$32,802 |
D/D |
(4,000) |
15,621 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-05-21 |
4 |
AS |
$18.54 |
$37,123 |
D/D |
(2,000) |
15,695 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Director |
|
2007-09-10 |
4 |
B |
$8.61 |
$17,357 |
D/D |
2,000 |
15,821 |
2.39 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-07 |
4 |
OE |
$12.99 |
$38,970 |
I/I |
3,000 |
16,545 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-05-12 |
4 |
OE |
$6.46 |
$32,300 |
D/D |
5,000 |
16,567 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-04-04 |
4 |
AS |
$17.70 |
$116,163 |
D/D |
(6,500) |
16,642 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-08-17 |
4 |
OE |
$6.46 |
$64,600 |
D/D |
10,000 |
16,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-09-19 |
4 |
OE |
$6.46 |
$64,600 |
D/D |
10,000 |
16,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-09-25 |
4 |
OE |
$6.46 |
$64,600 |
D/D |
10,000 |
16,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-04-03 |
4 |
AB |
$13.33 |
$20,019 |
D/D |
1,500 |
17,000 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-04-30 |
4 |
AB |
$6.92 |
$17,664 |
D/D |
2,553 |
17,695 |
0 |
- |
|
852 Records found
|
|
Page 5 of 35 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|